SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel coronavirus that emerged from Wuhan, China in late 2019 causing coronavirus disease-19 (COVID-19). SARS-CoV-2 infection begins by attaching to angiotensin-converting enzyme 2 receptor (ACE2) via the spike glycoprotein, followed...

Descripción completa

Detalles Bibliográficos
Autores principales: McGill, Andrew R., Kahlil, Roukiah, Dutta, Rinku, Green, Ryan, Howell, Mark, Mohapatra, Subhra, Mohapatra, Shyam S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931091/
https://www.ncbi.nlm.nih.gov/pubmed/33557330
http://dx.doi.org/10.3390/idr13010013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931091/
https://www.ncbi.nlm.nih.gov/pubmed/33557330
http://dx.doi.org/10.3390/idr13010013

Ejemplares similares